L
Leondios G. Kostrikis
Researcher at University of Cyprus
Publications - 86
Citations - 7580
Leondios G. Kostrikis is an academic researcher from University of Cyprus. The author has contributed to research in topics: Population & Genotype. The author has an hindex of 39, co-authored 82 publications receiving 7154 citations. Previous affiliations of Leondios G. Kostrikis include Aaron Diamond AIDS Research Center & National and Kapodistrian University of Athens.
Papers
More filters
Journal ArticleDOI
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
TL;DR: This review presents the current HPV testing methodologies, their application in organized population-based cervical cancer screening programs based on the most recent European guidelines, and their implementation status in countries in Europe.
Journal ArticleDOI
Short Communication: Determining Neutralization Serotypes of HIV Type 1 by Neural Networks
Journal ArticleDOI
HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012
Andrea-Clemencia Pineda-Peña,Andrea-Clemencia Pineda-Peña,Kristof Theys,Dora C. Stylianou,Ioannis Demetriades,Ana B. Abecasis,Ana B. Abecasis,Leondios G. Kostrikis +7 more
TL;DR: Young and drug-naïve HIV-1-infected individuals in Cyprus are driving the dynamics of the local HIV- 1 epidemic, and this methodology for analyzing densely sampled transmissiondynamics is applicable to other geographic regions to implement effective HIV-2 prevention strategies in local settings.
Journal ArticleDOI
Evidence for recent selection of the CCR5-delta 32 deletion from differences in its frequency between Ashkenazi and Sephardi Jews.
TL;DR: The results suggest that a positive selection process for ccr5-δ32 should have occurred in northern europe at most a 1000 years ago, after the ashkenazi jews separated from their sephardi kin and moved to north europe.
Journal ArticleDOI
Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy.
Giota Touloumi,Nikos Pantazis,Anastasia Karafoulidou,Titika Mandalaki,James J. Goedert,Leondios G. Kostrikis,Angelos Hatzakis +6 more
TL;DR: TREC values, which likely represent a simple indicator of naive T-lymphocyte reserve, may be a clinically useful marker for long-term prognosis of HIV-1 infection and for immune reconstitution after successful HAART.